Analyst Ranking
Bottom 7%
#4566 out of 4870 analysts
Average Return
-35.72%
Win Rate
27%4 out of 15
Risk vs Reward
Poor
Good

Yale Jen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nls Pharmaceutics LtdNLSP
+80.00%$24.00$43.20
2022-09-05 -
2023-09-05
Strong Buy
Evofem Biosciences IncEVFM
+38.95%$0.34$0.48
2022-06-01 -
2022-08-10
Strong Buy
Soleno Therapeutics IncSLNO
+11.32%$67.39$75.02
2025-03-26 -
2025-05-01
Strong Buy
Nuvectis Pharma IncNVCT
+1.37%$9.49$9.62
2025-03-16 -
2025-05-01
Strong Buy

Yale Jen Analyst Color

Get additional color on Yale Jen's coverage of popular stocks

Yale Jen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Soleno Therapeutics IncSLNO
1Strong Buy$105.00+39.96%Maintains
a month ago
Nuvectis Pharma IncNVCT
1Strong Buy$19.00+97.51%Initiates Coverage On
2 months ago
Lifeward LtdLFWD
1Strong Buy$10.00+619.42%Initiates Coverage On
3 months ago
Abivax SaABVX
1Strong Buy$48.00+594.65%Initiates Coverage On
9 months ago
Affimed NvAFMD
1Strong Buy$25.00+2,172.73%Maintains
a year ago
Biomx IncPHGE
1Strong Buy$25.00+4,210.34%Initiates Coverage On
a year ago
In8bio IncINAB
1Strong Buy$7.50N/AInitiates Coverage On
a year ago
Silo Pharma IncSILO
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Bellerophon Therapeutics IncBLPH
1Strong Buy$35.00N/AInitiates Coverage On
2 years ago
Nls Pharmaceutics LtdNLSP
1Strong Buy$240.00N/AInitiates Coverage On
3 years ago
Evofem Biosciences IncEVFM
1Strong Buy$3.50N/AInitiates Coverage On
3 years ago
Cingulate IncCING
1Strong Buy$2,040.00N/AInitiates Coverage On
3 years ago
Vincerx Pharma IncVINC
1Strong Buy$600.00N/AInitiates Coverage On
4 years ago
F Star Therapeutics IncFSTX
1Strong Buy$32.00N/AInitiates Coverage On
4 years ago
Athenex IncATNXQ
1Strong Buy$720.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.